{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:47:56Z","timestamp":1791179276897,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 AI142793-03"],"award-info":[{"award-number":["U19 AI142793-03"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tuberculosis (TB) is a major global health concern, with long-term complications persisting even after successful treatment. Chronic pulmonary aspergillosis (CPA) is a progressive fungal disease that frequently develops in TB survivors, contributing to post-TB lung disease. The true burden of CPA among patients with TB remains unclear due to diagnostic challenges and limited data. We aimed to estimate the prevalence of CPA among patients with prior or concurrent TB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic search in PubMed, Cochrane Library, Web of Science, and Science Direct through 10 January 2025. Eligible cohort and cross-sectional studies reported CPA prevalence in patients diagnosed with TB based on clinical symptoms, radiographic abnormalities, and microbiological evidence. Three reviewers screened 1575 unique studies, assessed 118 full texts, and included 22 studies (2884 patients). We conducted a meta-analysis using a random-effects model to estimate pooled CPA prevalence, with subgroup and meta-regression analyses exploring factors influencing CPA burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CPA prevalence varied by timing of assessment and symptom status. Among all patients with TB, CPA prevalence was 9% (95% confidence interval [CI]: 6%\u201312%) during treatment and 13% (95% CI: 6%\u201327%) posttreatment. Among patients with persistent respiratory symptoms, CPA prevalence was 20% during treatment and 48% (95% CI: 36%\u201361%) posttreatment. Meta-regression identified symptom status and timing of CPA assessment as significant predictors of CPA prevalence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The high CPA burden among TB survivors, particularly those with persistent symptoms, underscores the need for routine CPA screening in TB programs. Early detection and targeted interventions could reduce respiratory complications and improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaf150","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T20:40:11Z","timestamp":1742676011000},"page":"e163-e171","source":"Crossref","is-referenced-by-count":19,"title":["A Systematic Review of Chronic Pulmonary Aspergillosis Among Patients Treated for Pulmonary Tuberculosis"],"prefix":"10.1093","volume":"81","author":[{"given":"Alicia E","family":"Madden","sequence":"first","affiliation":[{"name":"Department of Global Health and Social Medicine, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia K","family":"Ofori","sequence":"additional","affiliation":[{"name":"Center for Communicable Disease Dynamics, Harvard T. H. Chan School of Public Health , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6091-7430","authenticated-orcid":false,"given":"Marian","family":"Budu","sequence":"additional","affiliation":[{"name":"Department of Global Health and Population, Harvard T. H. Chan School of Public Health , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6258-5743","authenticated-orcid":false,"given":"Emnet","family":"Sisay","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T. H. Chan School of Public Health , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Dooley","sequence":"additional","affiliation":[{"name":"Shannon Family Medicine Residency Clinic, Shannon Medical Center , San Angelo, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0443-1986","authenticated-orcid":false,"given":"Megan B","family":"Murray","sequence":"additional","affiliation":[{"name":"Department of Global Health and Social Medicine, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"2025110901572933000_ciaf150-B1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.15585\/mmwr.mm6811a3","article-title":"Global epidemiology of tuberculosis and progress toward achieving global targets\u20142017","volume":"68","author":"MacNeil","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025110901572933000_ciaf150-B2","author":"World Health Organization"},{"key":"2025110901572933000_ciaf150-B3","first-page":"1005","article-title":"Survival and predictors of death after successful treatment among smear positive tuberculosis: a cohort study","volume":"5","author":"Moosazadeh","year":"2014","journal-title":"Int J Prev Med"},{"key":"2025110901572933000_ciaf150-B4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijid.2019.05.024","article-title":"Morbidity and mortality up to 5 years post tuberculosis treatment in South Africa: a pilot study","volume":"85","author":"Osman","year":"2019","journal-title":"Int J Infect Dis"},{"key":"2025110901572933000_ciaf150-B5","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.ijid.2020.02.032","article-title":"Post tuberculosis treatment infectious complications","volume":"92S","author":"Hsu","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2025110901572933000_ciaf150-B6","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S1473-3099(22)00149-9","article-title":"Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017\u201319: a multistage, cluster-based, cross-sectional survey","volume":"22","author":"Moyo","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2025110901572933000_ciaf150-B7","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2471\/BLT.11.089441","article-title":"Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis","volume":"89","author":"Denning","year":"2011","journal-title":"Bull World Health Organ"},{"key":"2025110901572933000_ciaf150-B8","doi-asserted-by":"crossref","first-page":"e0161176","DOI":"10.1371\/journal.pone.0161176","article-title":"A systematic review of the prevalence and pattern of imaging defined post-TB lung disease","volume":"11","author":"Meghji","year":"2016","journal-title":"PLoS One"},{"key":"2025110901572933000_ciaf150-B9","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1086\/376526","article-title":"Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review","volume":"37","author":"Denning","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2025110901572933000_ciaf150-B10","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"key":"2025110901572933000_ciaf150-B11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/myc.12152","article-title":"Chronic pulmonary aspergillosis","volume":"57","author":"Schweer","year":"2014","journal-title":"Mycoses"},{"key":"2025110901572933000_ciaf150-B12","doi-asserted-by":"crossref","first-page":"myac063","DOI":"10.1093\/mmy\/myac063","article-title":"Chronic pulmonary aspergillosis is common among patients with presumed tuberculosis relapse in Ghana","volume":"60","author":"Ocansey","year":"2022","journal-title":"Med Mycol"},{"key":"2025110901572933000_ciaf150-B13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.5588\/ijtld.21.0034","article-title":"Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities","volume":"25","author":"Baluku","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025110901572933000_ciaf150-B14","doi-asserted-by":"crossref","first-page":"1601062","DOI":"10.1183\/13993003.01062-2016","article-title":"Predictors of mortality in chronic pulmonary aspergillosis","volume":"49","author":"Lowes","year":"2017","journal-title":"Eur Respir J"},{"key":"2025110901572933000_ciaf150-B15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1473-3099(24)00567-X","article-title":"Mortality in chronic pulmonary aspergillosis: a systematic review and individual patient data meta-analysis","volume":"25","author":"Sengupta","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025110901572933000_ciaf150-B16","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025110901572933000_ciaf150-B17","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025110901572933000_ciaf150-B18","doi-asserted-by":"crossref","first-page":"e171312","DOI":"10.3201\/eid2408.171312","article-title":"Case definition of chronic pulmonary aspergillosis in resource-constrained settings","volume":"24","author":"Denning","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2025110901572933000_ciaf150-B19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Software"},{"key":"2025110901572933000_ciaf150-B20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2025110901572933000_ciaf150-B21","author":"World Health Organization"},{"key":"2025110901572933000_ciaf150-B22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2025110901572933000_ciaf150-B23","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/sim.1752","article-title":"Controlling the risk of spurious findings from meta-regression","volume":"23","author":"Higgins","year":"2004","journal-title":"Stat Med"},{"key":"2025110901572933000_ciaf150-B24","doi-asserted-by":"crossref","first-page":"e13746","DOI":"10.1111\/myc.13746","article-title":"Innate and adaptive immune responses in subjects with CPA secondary to post-pulmonary tuberculosis lung abnormalities","volume":"67","author":"Chirumamilla","year":"2024","journal-title":"Mycoses"},{"key":"2025110901572933000_ciaf150-B25","doi-asserted-by":"crossref","first-page":"ofae090","DOI":"10.1093\/ofid\/ofae090","article-title":"Prevalence of chronic pulmonary aspergillosis in two (2) tuberculosis treatment clinics in Lagos, Nigeria: a prospective longitudinal study","volume":"11","author":"Davies","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2025110901572933000_ciaf150-B26","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s10096-015-2409-7","article-title":"Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran","volume":"34","author":"Hedayati","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025110901572933000_ciaf150-B27","doi-asserted-by":"crossref","first-page":"e13747","DOI":"10.1111\/myc.13747","article-title":"Chronic pulmonary aspergillosis incidence in newly detected pulmonary tuberculosis cases during follow-up","volume":"67","author":"Jha","year":"2024","journal-title":"Mycoses"},{"key":"2025110901572933000_ciaf150-B28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/jof8020130","article-title":"Serological changes in anti-Aspergillus IgG antibody and development of chronic pulmonary aspergillosis in patients treated for pulmonary tuberculosis","volume":"8","author":"Kim","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2025110901572933000_ciaf150-B29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3390\/jof8030301","article-title":"Incidence of chronic pulmonary aspergillosis in patients with suspected or confirmed NTM and TB\u2014a population-based retrospective cohort study","volume":"8","author":"Klinting","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2025110901572933000_ciaf150-B30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ijtb.2021.07.016","article-title":"Spectrum of pulmonary Aspergillus diseases in post TB lung diseases","volume":"69","author":"Lakhtakia","year":"2022","journal-title":"Indian J Tuberc"},{"key":"2025110901572933000_ciaf150-B31","doi-asserted-by":"crossref","first-page":"e0011284","DOI":"10.1371\/journal.pntd.0011284","article-title":"Prevalence and predictors of Aspergillus seropositivity and chronic pulmonary aspergillosis in an urban tertiary hospital in Sierra Leone: a cross-sectional study","volume":"17","author":"Lakoh","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"key":"2025110901572933000_ciaf150-B32","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s10096-023-04637-2","article-title":"Detection of serum Aspergillus-specific IgM and IgG antibody levels for the diagnosis of chronic pulmonary aspergillosis developed in patients with tuberculosis","volume":"42","author":"Mei","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025110901572933000_ciaf150-B33","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/myc.13444","article-title":"Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda","volume":"65","author":"Namusobya","year":"2022","journal-title":"Mycoses"},{"key":"2025110901572933000_ciaf150-B34","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/jof7070532","article-title":"Chronic pulmonary aspergillosis situation among post tuberculosis patients in Vietnam: an observational study","volume":"7","author":"Nguyen","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2025110901572933000_ciaf150-B35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/jof9010026","article-title":"Importance of Aspergillus-specific antibody screening for diagnosis of chronic pulmonary aspergillosis after tuberculosis treatment: a prospective follow-up study in Ghana","volume":"9","author":"Ocansey","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"2025110901572933000_ciaf150-B36","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.5588\/ijtld.17.0060","article-title":"Chronic pulmonary aspergillosis as a cause of smear-negative TB and\/or TB treatment failure in Nigerians","volume":"21","author":"Oladele","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025110901572933000_ciaf150-B37","doi-asserted-by":"crossref","first-page":"790134","DOI":"10.3389\/fcimb.2022.790134","article-title":"Prospective evaluation of positivity rates of Aspergillus-specific IgG and quality of life in HIV-negative tuberculosis patients in Lagos, Nigeria","volume":"12","author":"Oladele","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2025110901572933000_ciaf150-B38","doi-asserted-by":"crossref","first-page":"1801184","DOI":"10.1183\/13993003.01184-2018","article-title":"Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation","volume":"53","author":"Page","year":"2019","journal-title":"Eur Respir J"},{"key":"2025110901572933000_ciaf150-B39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/jof8040400","article-title":"Efficacy of LD Bio Aspergillus ICT lateral flow assay for serodiagnosis of chronic pulmonary aspergillosis","volume":"8","author":"Ray","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2025110901572933000_ciaf150-B40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11046-024-00917-3","article-title":"Performance of LDBio Aspergillus ICT IgM\/IgG lateral flow assay in diagnosing chronic pulmonary aspergillosis in community versus hospital setting","volume":"190","author":"Sehgal","year":"2025","journal-title":"Mycopathologia"},{"key":"2025110901572933000_ciaf150-B41","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/thoraxjnl-2020-216464","article-title":"A prospective longitudinal study of chronic pulmonary aspergillosis in pulmonary tuberculosis in Indonesia (APICAL)","volume":"77","author":"Setianingrum","year":"2022","journal-title":"Thorax"},{"key":"2025110901572933000_ciaf150-B42","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5588\/ijtld.20.0735","article-title":"Risk factors for chronic pulmonary aspergillosis in post-TB patients","volume":"25","author":"Singla","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025110901572933000_ciaf150-B43","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/jof10080529","article-title":"The association of chronic pulmonary aspergillosis and chronic pulmonary histoplasmosis with MDR-TB patients in Indonesia","volume":"10","author":"Soeroso","year":"2024","journal-title":"J Fungi (Basel)"},{"key":"2025110901572933000_ciaf150-B44","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/00494755221110678","article-title":"Prevalence of chronic pulmonary aspergillosis and the antifungal drug resistance of Aspergillus spp. in pulmonary tuberculosis patients in Uzbekistan","volume":"52","author":"Toychiev","year":"2022","journal-title":"Trop Doct"},{"key":"2025110901572933000_ciaf150-B45","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/myc.13465","article-title":"Prevalence of chronic pulmonary aspergillosis regarding time of tuberculosis diagnosis in Brazil","volume":"65","author":"Volpe-Chaves","year":"2022","journal-title":"Mycoses"},{"key":"2025110901572933000_ciaf150-B46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2334-14-107","article-title":"The effect of HIV and antiretroviral therapy on characteristics of pulmonary tuberculosis in northern Malawi: a cross-sectional study","volume":"14","author":"Munthali","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2025110901572933000_ciaf150-B47","doi-asserted-by":"crossref","first-page":"104018","DOI":"10.1016\/j.micpath.2020.104018","article-title":"Aspergillus coinfection among patients with pulmonary tuberculosis in Asia and Africa countries; a systematic review and meta-analysis of cross-sectional studies","volume":"141","author":"Hosseini","year":"2020","journal-title":"Microb Pathog"},{"key":"2025110901572933000_ciaf150-B48","first-page":"7","article-title":"New estimation of the prevalence of chronic pulmonary aspergillosis (CPA) related to pulmonary TB\u2014a revised burden for India","volume":"6","author":"Denning","year":"2023","journal-title":"Int J Infect Dis Reg"},{"key":"2025110901572933000_ciaf150-B49","first-page":"175","article-title":"What if they don\u2019t have tuberculosis? The consequences and trade-offs involved in false-positive diagnoses of tuberculosis","volume":"68","author":"Houben","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2025110901572933000_ciaf150-B50","first-page":"20499361241253751","article-title":"Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges","volume":"11","author":"Tashiro","year":"2024","journal-title":"Ther Adv Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf150\/62521328\/ciaf150.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/4\/e163\/62521328\/ciaf150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/4\/e163\/62521328\/ciaf150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:57:36Z","timestamp":1762671456000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/81\/4\/e163\/8090153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,3,21]]},"published-print":{"date-parts":[[2025,11,6]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf150","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10,15]]},"published":{"date-parts":[[2025,3,21]]}}}